Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	30.21	31.58	30.43	26.57	27.68
Cash & Short-Term Investments	30.21	31.58	30.43	26.57	27.68
Cash Growth	-28.85%	3.76%	14.55%	-4.01%	-
Other Current Assets	0.1	0.1	-	-	-
Total Current Assets	30.31	31.68	30.43	26.57	27.68
Total Assets	30.31	31.68	30.43	26.57	27.68
Net Cash (Debt)	30.21	31.58	30.43	26.57	27.68
Net Cash Growth	-4.34%	3.76%	14.55%	-4.01%	-
Net Cash Per Share	0.69	0.78	4.78	5.01	5.54

Updated Apr 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q